Skip to main content
. 2011 Jun 15;22(3):584–594. doi: 10.1093/cercor/bhr131

Figure 7.

Figure 7.

PKA-dependent tonic control of mEPSCs frequency. (A1) Bath application of forskolin (20 μM) enhanced mEPSC frequency. (A2) Pretreatment of slices with and continuous bath application of KT5720 (1 μM) counteracted forskolin-induced enhancement of mEPSC frequency. (B1) Bath application of IBMX (500 μM) significantly increased mEPSC frequency. (B2) Pretreatment of slices with and continuous bath application of KT5720 (1 μM) blocked IBMX-induced enhancement of mEPSC frequency. (C) Bath application of KT5720 (1 μM) reduced mEPSC frequency. (D) Bath application of MDL-12,330A (50 μM) inhibited mEPSC frequency.